北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 617-621. doi: 10.3969/j.issn.1671-167X.2017.04.012

• 论著 • 上一篇    下一篇

单中心14年B超引导下经皮肾肿物穿刺活检经验

张玉祥1*,蒙学兵2*,姚林1,张崔建1,宋刚1,蔡林1,张争1△,李学松1,龚侃1,李淑清1,山刚志1,何群1,杨新宇1,何志嵩1,周利群1   

  1. (1. 北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系统肿瘤研究中心,泌尿生殖系疾病(男)分子诊治北京市重点实验室, 北京100034; 2. 首都医科大学燕京医学院附属密云医院泌尿外科, 北京 101500)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 张争 E-mail: doczhz@aliyun.com

Percutaneous biopsy of the renal masses under ultrasound: a single-center 14 years experience

ZHANG Yu-xiang1*, MENG Xue-bing2*, YAO Lin1, ZHANG Cui-jian1, SONG Gang1, CAI Lin1, ZHANG Zheng1△, LI Xue-song1, GONG Kan1, LI Shu-qing1, SHAN Gang-zhi1, HE Qun1, YANG Xin-yu1, HE Zhi-song1, ZHOU Li-qun1   

  1. (1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center; Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing 100034, China; 2. Department of Urology, Miyun Hospital of Yanjing Medical College, Capital Medical University, Beijing 101500, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: ZHANG Zheng E-mail: doczhz@aliyun.com

摘要:  目的:评价B超引导下经皮肾肿物穿刺活检(renal masses biopsy, RMB)的诊断效果、安全性及在中晚期肾癌患者中的临床应用价值。方法:回顾性分析2001年4月至2014年12月在北京大学第一医院行B超引导下肾肿物穿刺活检的75例患者的临床病理资料,总结肿瘤大小、病理分型和分级、穿刺部位、穿刺针数以及诊断效果等数据,分组统计分析。结果:北京大学第一医院14年来B超引导下RMB数量呈明显增加趋势。共75例患者纳入本研究,确诊64例(85.3%),包括60例恶性肿瘤,4例良性病变;非诊断性穿刺11例(14.7%)。60例恶性肿瘤中,肾细胞癌37例(61.7%),尿路上皮癌13例(21.7%), 其他肿瘤10例(16.7%)。37例肾细胞癌中明确诊断病理学亚型33例(89.2%),无法明确病理学亚型4例(10.8%)。75例患者中,集合管癌占肾癌10.8%,鳞癌占尿路上皮癌23.1%,比例均高于已报道流行病学数据(2%,9.9%)。75例患者中,13例行手术治疗并取得术后病理,穿刺活检结果与术后病理结果相比,肿物良恶性、病理学亚型及病理分级诊断的准确率分别为100%、81.8%和60.0%。75例患者中1例(1.3%)出现轻微血尿,未出现其他相关并发症。结论:B超引导下RMB可准确诊断肾癌病理学亚型,指导晚期肾癌患者靶向治疗;RMB可较准确判断恶性程度较高的集合管癌、尿路上皮鳞癌,可为制定合理的治疗方案提供参考。

关键词: 癌, 肾细胞, 活组织检查, 诊断, 肿瘤, 组织学类型

Abstract: Objective: To assess the diagnostic rate, safety and clinical application of percutaneous renal masses biopsy for advanced renal cell carcinoma patients. Methods: In this retrospective study, we collected the data of renal masses from the patients who underwent renal masses biopsy under ultrasound from April 2001 to December 2014 in  Peking University First Hospital. A total of 75 patients who were undiagnosed or diagnosed with advanced renal cell carcinoma by the imageological method were enrolled in this study. The patient and lesion characteristics such as tumor size, pathology of tumor, histologic subtype, pathological grade, biopsied location and biopsied cores were recorded and analyzed. Results: Among all the 75 patients, biopsy was diagnostic in 64 cases (85.3%) and nondiagnostic in 11 cases (14.7%). Of the 64 diagnostic biopsies, 60 were malignant, including 37 (61.7%) renal cell carcinoma (RCC), 13 (21.7%) urothelial carcinoma and 10 (16.7%) other malignant masses. Of all the RCC subjects, 24 suffered from clear cell RCC, 5 papillary RCC, 3 collecting duct carcinomas, 1 unclassified RCC and 4 unknown subtypes. The 11 non-diagnostic biopsied samplings included inflammatory, blood and extrarenal tissue and normal renal tissue. The proportion of collecting duct carcinoma in RCC was 10.8% and the proportion of squamous carcinoma in urothelial carcinoma was 23.1%, which  were both higher than the previous research findings. For the male and female groups, non-diagnostic yields were 6.5% and 30.4%, respectively (P=0.022). Of all the 75 patients, 13 renal cell carcinoma patients underwent the surgical treatment and got the results of postoperative pathology. Comparing preoperative biopsy pathological diagnosis with postoperative pathological diagnosis, we found the diagnostic correct rates for benign and malignant lesions, pathological subtype and pathological grade were 100%, 81.8% and 60%, respectively. Mild macroscopic hematuria occurred in 1 case after RMB and there were no serious complications in all the cases. Conclusion: Percutaneous renal masses biopsy under ultrasound with a high diagnostic rate which can define the histologic subtype of renal cell carcinoma. With  targeted therapy, more and more patients whose evaluation suggests local advanced disease or metastatic tumors adopt renal tumor biopsy to define the histologic subtype, which could avoid unnecessary surgical treatment.

Key words: Carcinoma, renal cell, Biopsy, Diagnosis, Neoplasms, histologic type

中图分类号: 

  •  
[1] 季加孚, 韦静涛, 季科, 步召德. 胃癌诊疗的瓶颈与破局:迈向精准化与智能化融合的新纪元[J]. 北京大学学报(医学版), 2026, 58(2): 231-238.
[2] 步召德, 冯梦宇, 季科. 早期胃癌行前哨淋巴结导航手术的实践与思考[J]. 北京大学学报(医学版), 2026, 58(2): 239-243.
[3] 高加勒, 张忠涛. 局部进展期直肠癌精准治疗现状与展望[J]. 北京大学学报(医学版), 2026, 58(2): 247-250.
[4] 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256.
[5] 罗必显, 刘洪铭, 谢伟勋, 龚渭华. 产甲胎蛋白胃癌的新临床特征和前沿科学问题[J]. 北京大学学报(医学版), 2026, 58(2): 257-265.
[6] 付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报(医学版), 2026, 58(2): 266-271.
[7] 杜文, 章文博, 于尧, 刘硕, 苏惠裕, 胡耒豪, 唐祖南, 吴彬彰, 陈震, 李家琦, 王昊, 彭歆. 口腔颌面部肿瘤"数智化外科"诊疗流程探索与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 278-284.
[8] 王楠楠, 袁大晋, 朱昱冰, 丁磊. 结直肠癌根治术后肝转移风险多中心列线图预测模型的构建与验证[J]. 北京大学学报(医学版), 2026, 58(2): 290-300.
[9] 刘友东, 吕亚军, 陈杰, 臧明德, 潘宏达, 刘晓文, 陆俊, 刘凤林. 全腹腔镜保留贲门胃底胃次全切除术治疗中上部胃癌的疗效及安全性[J]. 北京大学学报(医学版), 2026, 58(2): 301-306.
[10] 殷昊明, 王子杰, 舒帆, 张展奕, 梁会, 张树栋. 肾透明细胞癌FABP6基因长转录本的表达及意义[J]. 北京大学学报(医学版), 2026, 58(2): 393-398.
[11] 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404.
[12] 郭芷均, 俎明, 马超, 张贺军, 张静, 丁士刚. 同时性多发早期胃癌漏诊病灶的临床病理特征[J]. 北京大学学报(医学版), 2026, 58(2): 410-415.
[13] 李斌, 梁寒. 机器人胃癌根治术:研究进展与实践挑战[J]. 北京大学学报(医学版), 2026, 58(2): 416-422.
[14] 董海峰, 陈恒星, 张常华. 恶性肿瘤中蛋白质乳酸化修饰的研究进展[J]. 北京大学学报(医学版), 2026, 58(2): 423-430.
[15] 潘子晨, 陈凯, 侯钰坤, 杨博涵, 张继新, 马永蔌, 田孝东, 杨尹默. 胰腺腺鳞癌临床病理特征与分子机制研究进展[J]. 北京大学学报(医学版), 2026, 58(2): 431-435.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!